Literature DB >> 17037604

Renilla luciferase as a reporter to assess SARS-CoV mRNA transcription regulation and efficacy of anti-SARS-CoV agents.

Rhonda S Roberts1, Boyd L Yount, Amy C Sims, Susan Baker, Ralph S Baric.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17037604      PMCID： PMC7122896          DOI： 10.1007/978-0-387-33012-9_108

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  2 in total

1.  Reverse genetics with a full-length infectious cDNA of severe acute respiratory syndrome coronavirus.

Authors:  Boyd Yount; Kristopher M Curtis; Elizabeth A Fritz; Lisa E Hensley; Peter B Jahrling; Erik Prentice; Mark R Denison; Thomas W Geisbert; Ralph S Baric
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-20       Impact factor: 11.205

2.  A novel coronavirus associated with severe acute respiratory syndrome.

Authors:  Thomas G Ksiazek; Dean Erdman; Cynthia S Goldsmith; Sherif R Zaki; Teresa Peret; Shannon Emery; Suxiang Tong; Carlo Urbani; James A Comer; Wilina Lim; Pierre E Rollin; Scott F Dowell; Ai-Ee Ling; Charles D Humphrey; Wun-Ju Shieh; Jeannette Guarner; Christopher D Paddock; Paul Rota; Barry Fields; Joseph DeRisi; Jyh-Yuan Yang; Nancy Cox; James M Hughes; James W LeDuc; William J Bellini; Larry J Anderson
Journal:  N Engl J Med       Date:  2003-04-10       Impact factor: 91.245
  2 in total
  4 in total

1.  Safe and Sensitive Antiviral Screening Platform Based on Recombinant Human Coronavirus OC43 Expressing the Luciferase Reporter Gene.

Authors:  Liang Shen; Yang Yang; Fei Ye; Gaoshan Liu; Marc Desforges; Pierre J Talbot; Wenjie Tan
Journal:  Antimicrob Agents Chemother       Date:  2016-08-22       Impact factor: 5.191

2.  Coronavirus replicase-reporter fusions provide quantitative analysis of replication and replication complex formation.

Authors:  Megan Culler Freeman; Rachel L Graham; Xiaotao Lu; Christopher T Peek; Mark R Denison
Journal:  J Virol       Date:  2014-03-12       Impact factor: 5.103

3.  A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19.

Authors:  Xuping Xie; Antonio E Muruato; Xianwen Zhang; Kumari G Lokugamage; Camila R Fontes-Garfias; Jing Zou; Jianying Liu; Ping Ren; Mini Balakrishnan; Tomas Cihlar; Chien-Te K Tseng; Shinji Makino; Vineet D Menachery; John P Bilello; Pei-Yong Shi
Journal:  Nat Commun       Date:  2020-10-15       Impact factor: 14.919

4.  mRNA display design of fibronectin-based intrabodies that detect and inhibit severe acute respiratory syndrome coronavirus nucleocapsid protein.

Authors:  Hsiang-I Liao; C Anders Olson; Seungmin Hwang; Hongyu Deng; Elaine Wong; Ralph S Baric; Richard W Roberts; Ren Sun
Journal:  J Biol Chem       Date:  2009-04-13       Impact factor: 5.157
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.